You are here : Home / All Sectors / Healthcare / Hospital & Healthcare Services / INDRAPRASTHA MEDICAL CORPORATION

INDRAPRASTHA MEDICAL CORPORATION
Intrinsic Value | Fundamental Analysis

Returns | 1W : 0.1% , 1M : 50.5%,1Y : 99.5%
BOM : 532150     NSE : INDRAMEDCO    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
May 18,2021
Price(EOD): Rs. 84.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 777.62 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
INDRAPRASTHA MEDICAL CORPORATION 0.1% 50.5% 99.5%
APOLLO HOSPITALS ENTERPRISE -3% 5.7% 143.6%
DR LAL PATHLABS -1.4% -4.7% 72.6%
FORTIS HEALTHCARE -5.6% 8.1% 90.3%
METROPOLIS HEALTHCARE 2.1% -3.3% 82.4%
ASTER DM HEALTHCARE -3.3% 9.4% 64.4%
NARAYANA HRUDAYALAYA 5.4% 1.1% 69.3%
THYROCARE TECHNOLOGIES -3.4% -0.8% 99.9%
SHALBY -4.6% 37.9% 169.7%


FUNDAMENTAL ANALYSIS OF INDRAPRASTHA MEDICAL CORPORATION

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than INDRAPRASTHA MEDICAL CORPORATION Premium


VALUATION OF INDRAPRASTHA MEDICAL CORPORATION

 
Valuation Score
Ratio Standalone
P/E
P/B
P/S
17.82
P/E Calculated based on EPS of 4.76
[ Mar2020 - Standalone Results ]

2.9
P/B Calculated based on Book Value of 29.21
[ Mar2020 - Standalone Results ]

1.08
P/S Calculated based on Revenues of 721.29 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than INDRAPRASTHA MEDICAL CORPORATION Premium


FAIR VALUE OF INDRAPRASTHA MEDICAL CORPORATION

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
56%
34%
63%

SHARE PRICE MOMENTUM OF INDRAPRASTHA MEDICAL CORPORATION

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.01
0.09
0.28
0.13
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
27.59%
174.66%
3808.12%
2636.3%
-14.45%
9.83%
21.25%
12.24%
QtrlyTrend
6
Latest Qtr: Dec2020

INDRAPRASTHA MEDICAL CORPORATION related INDICES

BSE Indices1W1M1Y
S&P BSE ALLCAP 1.5% 5.2% 70.6%
S&P BSE MIDSMALLCAP 1.2% 8.3% 96.1%
S&P BSE SMALL CAP 1.1% 9.9% 110.7%
S&P BSE HEALTHCARE -1.6% 6.9% 59.5%
No NSE index found

FAQ [Frequently Asked Questions]


Is INDRAMEDCO good for long term investment?

As on 18-May-2021, the Fundamentals of INDRAMEDCO are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of INDRAPRASTHA MEDICAL CORPORATION . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is INDRAMEDCO UnderValued or OverValued?

As on 18-May-2021, INDRAMEDCO is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of INDRAMEDCO ?

As on 18-May-2021, the Intrinsic Value of INDRAMEDCO is Rs. 54.25 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 54.25
Fair Value [Median EV / Sales Model] : Rs. 63.25
Fair Value [Median Price / Sales Model] : Rs. 51.91
Median Fair Value of INDRAMEDCO : Rs. 54.25

Is INDRAMEDCO trading at a Premium or Discount?

As on 18-May-2021, INDRAMEDCO is trading at a Premium of 56% based on the Median Intrinsic Value!

Is it right time to buy INDRAMEDCO shares?

As on 18-May-2021, INDRAMEDCO is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of INDRAMEDCO?

Check out Financials of Industry Peers using below links:
Financials of APOLLO HOSPITALS ENTERPRISE LTD
Financials of DR LAL PATHLABS LTD
Financials of FORTIS HEALTHCARE LTD
Financials of METROPOLIS HEALTHCARE LTD
Financials of ASTER DM HEALTHCARE LTD
Financials of NARAYANA HRUDAYALAYA LTD
Financials of THYROCARE TECHNOLOGIES LTD
Financials of SHALBY LTD
Financials of KOVAI MEDICAL CENTER & HOSPITAL LTD
Financials of KMC SPECIALITY HOSPITALS (INDIA) LTD

What are the Frequent Comparisons with INDRAMEDCO?

INDRAPRASTHA MEDICAL CORPORATION LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs DR LAL PATHLABS LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs METROPOLIS HEALTHCARE LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs ASTER DM HEALTHCARE LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs NARAYANA HRUDAYALAYA LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs THYROCARE TECHNOLOGIES LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs SHALBY LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs KOVAI MEDICAL CENTER & HOSPITAL LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs KMC SPECIALITY HOSPITALS (INDIA) LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z